176 related articles for article (PubMed ID: 11829518)
1. Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression.
Ruzek MC; Kavanagh BF; Scaria A; Richards SM; Garman RD
Mol Ther; 2002 Feb; 5(2):115-24. PubMed ID: 11829518
[TBL] [Abstract][Full Text] [Related]
2. A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo.
Zhu J; Huang X; Yang Y
Mol Ther; 2008 Jul; 16(7):1300-7. PubMed ID: 18443600
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene.
Korst RJ; Ailawadi M; Lee JM; Lee S; Yamada R; Mahtabifard A; Crystal RG
Hum Gene Ther; 2001 Sep; 12(13):1639-49. PubMed ID: 11535167
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
Song W; Kong HL; Traktman P; Crystal RG
Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
[TBL] [Abstract][Full Text] [Related]
5. Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation.
Peng Y; Falck-Pedersen E; Elkon KB
J Virol; 2001 May; 75(10):4540-50. PubMed ID: 11312324
[TBL] [Abstract][Full Text] [Related]
6. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
7. Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors.
Camargo FD; Huey-Louie DA; Finn AV; Sassani AB; Cozen AE; Moriwaki H; Schneider DB; Agah R; Dichek DA
Mol Ther; 2000 Nov; 2(5):496-504. PubMed ID: 11082323
[TBL] [Abstract][Full Text] [Related]
8. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
9. NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus.
Zhu J; Huang X; Yang Y
J Immunol; 2010 Dec; 185(12):7480-6. PubMed ID: 21076062
[TBL] [Abstract][Full Text] [Related]
10. Innate immune responses to adenoviral vector-mediated acute pancreatitis.
Shifrin AL; Chirmule N; Gao GP; Wilson JM; Raper SE
Pancreas; 2005 Mar; 30(2):122-9. PubMed ID: 15714134
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
Hirschowitz EA; Crystal RG
Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells.
Tran J; Kung SK
Mol Ther; 2007 Jul; 15(7):1331-9. PubMed ID: 17505478
[TBL] [Abstract][Full Text] [Related]
14. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer.
Zhu J; Huang X; Yang Y
J Virol; 2012 Dec; 86(24):13689-96. PubMed ID: 23055553
[TBL] [Abstract][Full Text] [Related]
16. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice.
Fu YH; He JS; Zheng XX; Wang XB; Xie C; Shi CX; Zhang M; Tang Q; Wei W; Qu JG; Hong T
Biochem Biophys Res Commun; 2010 Jan; 391(1):857-61. PubMed ID: 19945423
[TBL] [Abstract][Full Text] [Related]
19. Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens.
Perricone MA; Claussen KA; Smith KA; Kaplan JM; Piraino S; Shankara S; Roberts BL
Mol Ther; 2000 Mar; 1(3):275-84. PubMed ID: 10933943
[TBL] [Abstract][Full Text] [Related]
20. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
